ArticleCancer science2025

NFATc4 Promotes Lung Adenocarcinoma Progression via the CCNB1/CDK1 Pathway and Is a Potential Prognostic Biomarker.

Wendi Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.